$24.61
1.56% yesterday
Nasdaq, May 20, 09:50 pm CET
ISIN
US74276R1023
Symbol
PRVA

Privia Health Group Target price 2025 - Analyst rating & recommendation

Privia Health Group Classifications & Recommendation:

Buy
91%
Hold
9%

Privia Health Group Price Target

Target Price $30.43
Price $24.52
Potential
Number of Estimates 21
21 Analysts have issued a price target Privia Health Group 2026 . The average Privia Health Group target price is $30.43. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 20 Analysts recommend Privia Health Group to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Privia Health Group stock has an average upside potential 2026 of . Most analysts recommend the Privia Health Group stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 1.74 1.90
4.74% 9.71%
EBITDA Margin 1.40% 5.73%
14.82% 310.29%
Net Margin 0.77% 1.34%
44.73% 74.25%

21 Analysts have issued a sales forecast Privia Health Group 2025 . The average Privia Health Group sales estimate is

$1.9b
Unlock
. This is
5.76% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.0b 10.98%
Unlock
, the lowest is
$1.9b 3.83%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $1.7b 4.74%
2025
$1.9b 9.71%
Unlock
2026
$2.1b 10.40%
Unlock
2027
$2.4b 12.66%
Unlock
2028
$2.7b 14.20%
Unlock
2029
$3.1b 13.12%
Unlock

21 Analysts have issued an Privia Health Group EBITDA forecast 2025. The average Privia Health Group EBITDA estimate is

$109m
Unlock
. This is
280.08% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$111m 284.72%
Unlock
, the lowest is
$108m 274.52%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $24.3m 10.78%
2025
$109m 350.29%
Unlock
2026
$130m 18.89%
Unlock
2027
$155m 19.54%
Unlock
2028
$183m 17.88%
Unlock
2029
$216m 17.96%
Unlock

EBITDA Margin

2024 1.40% 14.82%
2025
5.73% 310.29%
Unlock
2026
6.17% 7.68%
Unlock
2027
6.55% 6.16%
Unlock
2028
6.76% 3.21%
Unlock
2029
7.05% 4.29%
Unlock

14 Privia Health Group Analysts have issued a net profit forecast 2025. The average Privia Health Group net profit estimate is

$25.4m
Unlock
. This is
74.58% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$35.2m 141.65%
Unlock
, the lowest is
$14.6m 0.02%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $13.4m 42.11%
2025
$25.4m 90.45%
Unlock
2026
$40.9m 60.91%
Unlock
2027
$56.7m 38.49%
Unlock
2028
$75.3m 32.80%
Unlock
2029
$94.1m 25.01%
Unlock

Net Margin

2024 0.77% 44.73%
2025
1.34% 74.25%
Unlock
2026
1.95% 45.52%
Unlock
2027
2.39% 22.56%
Unlock
2028
2.78% 16.32%
Unlock
2029
3.07% 10.43%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.11 0.21
42.11% 90.91%
P/E 117.03
EV/Sales 1.35

14 Analysts have issued a Privia Health Group forecast for earnings per share. The average Privia Health Group EPS is

$0.21
Unlock
. This is
75.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$0.29 141.67%
Unlock
, the lowest is
$0.12 0.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.11 42.11%
2025
$0.21 90.91%
Unlock
2026
$0.34 61.90%
Unlock
2027
$0.47 38.24%
Unlock
2028
$0.62 31.91%
Unlock
2029
$0.78 25.81%
Unlock

P/E ratio

Current 198.38 76.31%
2025
117.03 41.01%
Unlock
2026
72.74 37.84%
Unlock
2027
52.52 27.80%
Unlock
2028
39.55 24.70%
Unlock
2029
31.64 20.00%
Unlock

Based on analysts' sales estimates for 2025, the Privia Health Group stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.43 40.20%
2025
1.35 5.45%
Unlock
2026
1.22 9.42%
Unlock
2027
1.09 11.24%
Unlock
2028
0.95 12.43%
Unlock
2029
0.84 11.60%
Unlock

P/S ratio

Current 1.66 38.83%
2025
1.57 5.45%
Unlock
2026
1.42 9.42%
Unlock
2027
1.26 11.24%
Unlock
2028
1.10 12.44%
Unlock
2029
0.98 11.59%
Unlock

Current Privia Health Group Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JMP Securities
Locked
Locked
Locked Apr 28 2025
Baird
Locked
Locked
Locked Apr 15 2025
Truist Securities
Locked
Locked
Locked Apr 10 2025
Needham
Locked
Locked
Locked Apr 10 2025
Barclays
Locked
Locked
Locked Apr 10 2025
Needham
Locked
Locked
Locked Mar 21 2025
Needham
Locked
Locked
Locked Feb 28 2025
Analyst Rating Date
Locked
JMP Securities:
Locked
Locked
Apr 28 2025
Locked
Baird:
Locked
Locked
Apr 15 2025
Locked
Truist Securities:
Locked
Locked
Apr 10 2025
Locked
Needham:
Locked
Locked
Apr 10 2025
Locked
Barclays:
Locked
Locked
Apr 10 2025
Locked
Needham:
Locked
Locked
Mar 21 2025
Locked
Needham:
Locked
Locked
Feb 28 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today